Category: Alzheimer’s

Eisai Co said Monday that it has applied for marketing authorization from Japan’s Pharmaceuticals and Medical Devices Agency for a new Alzheimer’s drug jointly developed with U.S. pharmaceutical company Biogen Inc.

Japanese drugmaker Eisai Co. and U.S. biopharmaceutical company Biogen Inc. said Wednesday an Alzheimer’s drug they are jointly developing has been found effective in slowing the deterioration of symptoms in a late-stage clinical trial.